CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 114 filers reported holding CHEMOCENTRYX INC in Q2 2018. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $826,000 | +187.8% | 62,730 | +197.2% | 0.06% | +172.7% |
| Q1 2018 | $287,000 | -67.7% | 21,104 | -77.8% | 0.02% | -66.2% |
| Q2 2017 | $888,000 | +71.8% | 94,897 | +33.4% | 0.06% | +80.6% |
| Q1 2017 | $517,000 | -33.4% | 71,142 | -32.2% | 0.04% | -33.3% |
| Q4 2016 | $776,000 | +31.3% | 104,999 | +7.2% | 0.05% | +25.6% |
| Q3 2016 | $591,000 | +74.9% | 97,975 | +30.1% | 0.04% | +87.0% |
| Q2 2016 | $338,000 | -81.0% | 75,299 | -76.5% | 0.02% | -87.2% |
| Q3 2013 | $1,778,000 | – | 319,868 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |